Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘FDA’

April 6, 2020

Mayo Clinic Research in the News — Week in Review 4/6/2020

By Elizabeth Zimmermann Elizabeth Zimmermann

In the last week, as you might imagine, most of the news being covered by the media is about COVID-19. We’ve included an excerpt and link to several of these stories discussing Mayo Clinic Research. We found a couple items covering other things we are working on, so included them first, for your awareness. Study: […]

View full entry

Tags: blood test, cancer, cancer screening, cardiology, clinical trials, COVID-19, FDA, Gregory Poland, Henry Ting, immune system, Mayo Clinic Laboratories, Michael Ackerman


April 1, 2020

Research News Roundup–March 2020

By Elizabeth Zimmermann Elizabeth Zimmermann

Even though it’s April Fool’s Day, the stories we share in this monthly column are no joke. Because since last month our world has shifted focus, we’ve divided these releases into two sections – COVID-related, and everything else. “Everything else” is at the end this month, because it is the bigger section, with nearly a […]

View full entry

Tags: AFib, Alzheimer's disease, anesthesiology, cardiology, cardiovascular medicine, clinical trials, COVID-19, Department of Laboratory Medicine and Pathology, FDA, Fredric Meyer, heart attack, heart disease


August 19, 2019

Yale and Mayo Clinic awarded FDA grant to study opioid prescribing and use

By Advancing the Science contributor Advancing the Science contributor

— Yale University Office of Public Affairs & Communications Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), […]

View full entry

Tags: Center for the Science of Health Care Delivery, FDA, Nilay Shah, opioids


May 3, 2016

OLD DRUG OR NEW?

By Elizabeth Zimmermann Elizabeth Zimmermann

Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily. However, from the 1950s until just recently, warfarin was […]

View full entry

Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, FDA, Neena Abraham


Contact Us · Privacy Policy